Back
Enterprise Financial Services Vs. Dyne Therapeutics Industry Stock Comparison
Sell
27
EFSC
Enterprise Financial Services
Last Price:
38.95
Seasonality Move:
1.95%
Buy
70
DYN
Dyne Therapeutics
Last Price:
35.41
Seasonality Move:
29.58%
Sell
27
Enterprise Financial Services (EFSC)
is a Sell
Is Enterprise Financial Services a Buy, Sell or Hold?
- The current Enterprise Financial Services [EFSC] share price is $39.01. The Score for EFSC is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- EFSC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Dyne Therapeutics (DYN)
is a Buy
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $35.42. The Score for DYN is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EFSC Stock Price Chart
What is Enterprise Financial Services's stock price today?
-
The Enterprise Financial Services share price today is $39.01
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EFSC is experiencing buying pressure, which is a positive indicator for future bullish movement.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $35.42
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.
EFSC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 54.54 | Buy |
| Chaikin Money Flow: | 85030 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.9 - 38.74) | Buy |
| Bollinger Bands (100): | (38.25 - 40.05) | Sell |
DYN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.37 | Buy |
| Relative Strength Index (14 RSI): | 61.67 | Buy |
| Chaikin Money Flow: | 824776 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.96 - 33.9) | Buy |
| Bollinger Bands (100): | (24.09 - 31.13) | Buy |
EFSC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.5 | Buy |
| 20-day SMA: | 38.29 | Buy |
| 50-day SMA: | 38.87 | Buy |
| 200-day SMA: | 39.49 | Sell |
| 8-day EMA: | 38.56 | Buy |
| 20-day EMA: | 38.51 | Buy |
| 50-day EMA: | 38.79 | Buy |
| 200-day EMA: | 39.99 | Sell |
DYN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.9 | Buy |
| 20-day SMA: | 32.78 | Buy |
| 50-day SMA: | 29.47 | Buy |
| 200-day SMA: | 19.6 | Buy |
| 8-day EMA: | 34.1 | Buy |
| 20-day EMA: | 32.84 | Buy |
| 50-day EMA: | 30.41 | Buy |
| 200-day EMA: | 22.49 | Buy |
Enterprise Financial Services Earnings Growth & EFSC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.73 per share, and an increase next year of $0.07 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.77 per share, and an increase next year of $0.16 per share.
Enterprise Financial Services Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dyne Therapeutics Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||